Sana Biotechnology (SANA) Stock Price, Quote, News & History | Benzinga

Sana Biotechnology Inc (SANA) Stock Price, Quote, News & History

SANANASDAQ

Trade with Public

Trade with Public

$3.82

-0.01-0.26%

Last update: Sep 2, 9:30 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.85

Close

-

Volume / Avg.

1.30M / 3.07M

Day Range

$3.80 - $4.08

52 Wk Range

2.61 - 6.55

Market Cap

$1.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24%

Days to Cover

17.97

Recent Sana Biotechnology, Inc. News

Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race

Kailera Therapeutics prices $625 million IPO, advances GLP-1 obesity pipeline as trial data highlights oral ribupatide weight loss results.

Vandana Singh

Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday

Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TVTX, BE, IONQ, SANA, RGTI, VACH, AOSL.

Avi Kapoor

Why Bloom Energy Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Bloom Energy (BE) rose in pre-market trading as it announces expanded partnership with Oracle (ORCL). Other gainers include PMNT, SNYR, SNAL, HOTH, HUBC, GPRO, FCHL, SANA, and CRDO. Losers include CMCT, CUE, WHLR, and GCTK.

Avi Kapoor

Stock Market Today: S&P 500, Nasdaq Futures Rise As JD Vance Touts 'Good Deal' If Iran Meets US 'Red Lines'—Sana, Chevron In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data and the headline were updated in the story. U.S. stocks rose on Tuesday, following Monday’s rally. Futures of the major benchmark indices were trading higher.

Rishabh Mishra

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-132.24M

Investing Cash Flow (TTM)

-102.60M

Financing Cash Flow (TTM)

220.64M

Free Cash Flow (TTM)

-135.06M

Capital Expenditure (TTM)

-2.82M

Net Change in Cash (TTM)

-14.20M

Analyst Trends and Forecast

1

Mar

1

Apr

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.06B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

7.43

Earnings Yield % (TTM)

-19.56%

Earnings Yield % (FWD)

-15.12%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.52

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$57.07M

Debt to Equity

0.48

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.85

Close

-

Volume / Avg.

1.30M / 3.07M

Day Range

$3.80 - $4.08

52 Wk Range

2.61 - 6.55

Market Cap

$1.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24%

Days to Cover

17.97

About

Sector

Health Care

Industry

Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatmen...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sana Biotechnology (SANA) stock?

A

You can purchase shares of Sana Biotechnology (NASDAQ:SANA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sana Biotechnology (SANA) competitors?

A

Other companies in Sana Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Sana Biotechnology (SANA) stock?

A

Sana Biotechnology has a consensus price target of $7.90.

Q

What is the current price for Sana Biotechnology (SANA)?

A

The stock price for Sana Biotechnology (NASDAQ: SANA) is $3.82 last updated September 2, 2026 at 9:30 AM EDT.

Q

Does Sana Biotechnology (SANA) pay a dividend?

A

There are no upcoming dividends for Sana Biotechnology.

Q

When is Sana Biotechnology (NASDAQ:SANA) reporting earnings?

A

Sana Biotechnology does not have any upcoming earnings scheduled.

Q

Is Sana Biotechnology (SANA) going to split?

A

There is no upcoming split for Sana Biotechnology.

Q

What sector and industry does Sana Biotechnology (SANA) operate in?

A

Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.